Zensun is seeking tight IP protection to drug candidates under development and nearly a hundred of patent applications have been filed globaly by now. Fifteen patents have been granted to date, with eight patents in connection with Neuregulin and 7 patents in connection with anti-tumor antibody and/or vaccine. The main martkets all over the world such as US and European countries have been covered by these patents.